AUCH Medical Directors Peer Group

Use of COVID-19 Vaccines in the United States Interim Clinical Considerations from the CDC 

09-09-2022 16:38

Summary of recent changes (last updated September 2, 2022):
  • New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA booster after completion of a monovalent primary series; it replaces all prior booster recommendations for this age group
    • Recommendations for use of a bivalent Moderna booster dose in people ages 18 years and older
    • Recommendations for use of a bivalent Pfizer-BioNTech booster dose in people ages 12 years and older
  • Updated guidance for observation periods following COVID-19 vaccination
  • Updated guidance on COVID-19 vaccination and multisystem inflammatory syndrome (MIS) in children (MIS-C) and in adults (MIS-A)

Statistics
0 Favorited
1 Views
0 Files
0 Shares
0 Downloads

Tags and Keywords

Related Entries and Links

No Related Resource entered.